Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000076227 | SCV000107250 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability <0.001 |
Invitae | RCV000524351 | SCV000262285 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000625493 | SCV000430927 | likely benign | Lynch syndrome 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Color Diagnostics, |
RCV000579780 | SCV000684961 | benign | Hereditary cancer-predisposing syndrome | 2015-02-18 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000625493 | SCV000781772 | uncertain significance | Lynch syndrome 1 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000202150 | SCV000806007 | benign | not specified | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711177 | SCV001939607 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000202150 | SCV002070919 | benign | not specified | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579780 | SCV002706545 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV000202150 | SCV002760646 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149747 | SCV003837626 | benign | Breast and/or ovarian cancer | 2021-11-09 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000625493 | SCV004015952 | benign | Lynch syndrome 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000202150 | SCV000257148 | uncertain significance | not specified | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV001354042 | SCV000592514 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The MSH2 c.1662-9G>A variant was identified in 3 of 584 proband chromosomes (frequency: 0.005) from individuals or families with colorectal cancer (Montera 2000, Farrington 1998, Thompson 2013). The variant was also identified in dbSNP (ID: rs17218356) as “With other allele”, ClinVar (classified as benign by an InSiGHT expert panel (2013) and five other submitters; as likely benign by 2 submitters; and as uncertain significance by 2 submitters). The variant was not identified in UMD-LSDB. The variant was also identified in control databases in 465 (4 homozygous) of 276212 chromosomes at a frequency of 0.002, increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 386 (4 homozygous) of 23980 chromosomes (freq: 0.02), Other in 14 of 6450 chromosomes (freq: 0.002), Latino in 38 of 34372 chromosomes (freq: 0.001), European Non-Finnish in 22 of 126108 chromosomes (freq: 0.0002), East Asian in 2 of 18846 chromosomes (freq: 0.0001), and South Asian in 3 of 30556 chromosomes (freq: 0.0001), while it was not observed in the Ashkenazi Jewish or European Finnish populations. The c.1662-9G>A variant is located in the 3' splice region but does not affect the invariant -1 and -2 positions, although positions -3 and -5 to -12 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. However, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. Furthermore, in vitro splicing analysis performed by Thompson (2013) determined the splicing of this allele to be similar to wild type. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. | |
Genome Diagnostics Laboratory, |
RCV000625493 | SCV000745640 | benign | Lynch syndrome 1 | 2017-09-07 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000202150 | SCV001920221 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000202150 | SCV001959119 | benign | not specified | no assertion criteria provided | clinical testing |